复旦张江公告，预计公司2025年年度实现归属于母公司所有者的净利润与上年同期相比，将出现亏损， 预计2025年年度实现归属于母公司所有者的净利润为人民币-18,000万元至人民币-12,000万元。本集团 积极推动研发项目进展，研发投入占营业收入比例持续上升。 ...

Core Viewpoint - The company Zhongyan Co., Ltd. (688716) has announced a significant decline in its expected net profit for 2025, forecasting a 69.96% decrease year-on-year, which raises concerns about its financial health and market position [4]. Financial Performance - The expected net profit for 2025 is projected at 11.8 million yuan, down from previous years [4]. - The expected non-recurring net profit is forecasted to be 4.79 million yuan, reflecting an 80.47% decline year-on-year [4]. - Historical net profit and non-recurring net profit figures show a downward trend, with the company experiencing a significant drop in profitability over the years [8]. Valuation Metrics - As of January 30, the company's price-to-earnings (P/E) ratio is approximately 430 times, the price-to-book (P/B) ratio is about 4.29 times, and the price-to-sales (P/S) ratio is around 17.44 times [4]. - The P/E and P/S ratios are calculated using the trailing twelve months (TTM) data, while the P/B ratio is based on the latest financial report [12]. Business Operations - The company specializes in resin-based PEEK products and has been actively expanding its market presence [7]. - Despite the decline in net profit, the parent company's revenue and net profit have shown growth compared to the previous year, indicating some operational resilience [7]. - Increased investment in research and development and the establishment of a Shanghai R&D center are part of the company's strategy to enhance its core product competitiveness [7].

Core Viewpoint - The company anticipates a revenue increase for 2025, with a projected range of 908 million to 1 billion yuan, reflecting a year-on-year growth of approximately 10.07% to 21.22% [1] Group 1: Financial Projections - The expected net profit attributable to the parent company for 2025 is projected to be between -20 million and -13.5 million yuan, indicating a narrowing of losses compared to the previous year [1] - The anticipated net profit attributable to the parent company, excluding non-recurring gains and losses, is estimated to be between -22 million and -15 million yuan [1] Group 2: Business Strategy and Market Position - The company is focusing on market opportunities by optimizing product structure and enhancing order acquisition capabilities, which has led to a revenue increase of approximately 10.07% to 21.22% year-on-year [1] - Core products such as automotive high-speed cables and high-performance data cables have demonstrated strong market competitiveness [1] Group 3: Cost Factors and Challenges - Profitability is impacted by several factors, including employee incentives and uncontrollable external factors, such as approximately 27.3 million yuan in share-based payment expenses from the 2024 employee stock ownership plan and around 11.94 million yuan in exchange losses due to the depreciation of the US dollar [1] - To strengthen its position in the automotive high-speed cable sector, the company is increasing R&D investment, expanding production lines, and enhancing its technical, sales, and management teams, which has led to higher R&D and sales management expenses affecting current profits [1]

年度归母净利润从2023年超过11亿元的巅峰跌落至预计亏损最高3.8亿元，短短两年时间，曾凭借一句"小葵花妈妈课堂开课了"广告语家喻户晓的儿童药 巨头，正经历着上市以来最严峻的考验。 1月29日晚间，葵花药业发布2025年度业绩预告，公司预计2025年归母净利润为-3.80亿元至-2.40亿元，上年同期为4.92亿元，同比下降 177.23%~148.78%；预计扣非归母净利润为-4.20亿元至-2.85亿元，上年同期为3.45亿元，同比下降182.68%~182.68%。 二是产销数量减少，固定成本分摊提升，毛利率同比降低。受公司上游中药材市场价格波动较大，叠加公司2025年销量大幅下降的影响，公司单位产品固 定制造费用无法摊薄、部分产品的生产成本处于高位，导致公司整体毛利率下降。在公司产销恢复常态后，公司成本承压态势将逐步改善。 | | | | 项 目 | 本报告期 | | | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司 | | -38.000 | ﺑﮩ | -24.000 | 49.204. 54 | | 股东的净利润 | 比上年同期 ...

Core Viewpoint - Shaanxi Huada (301517.SZ) expects a loss of 59 million to 79 million yuan in 2025, compared to a profit of 46.64 million yuan in the same period last year, indicating a significant downturn in financial performance [1] Financial Performance - The company anticipates a net loss of 59 million to 79 million yuan for 2025, with a non-recurring loss projected between 65 million to 85 million yuan [1] - In the previous year, the company reported a profit of 46.64 million yuan [1] Business Segment Analysis - The defense sector experienced a decline in product prices, which, along with factors such as client project timelines and product acceptance cycles, led to revenue recognition falling short of expected targets [1] - The aerospace business segment is showing steady development with enhanced project tracking [1] - The civil communication sector remains stable [1] Operational Challenges - The overall operational efficiency is under pressure due to rising prices of precious metals and other materials required for production, as well as the need to make impairment provisions [1] Future Outlook - The company is focusing on cutting-edge technologies and industry development directions, increasing R&D investment, which has seen a year-on-year growth in R&D expenses, thereby strengthening its research capabilities for future development [1]

中证智能财讯精研科技（300709）1月29日晚间披露2025年度业绩预告，预计2025年归母净利润4500万元至6000万元，同比下降49.87%-62.4%；扣非净利润 预计3000万元-4200万元，同比下降58.41%-70.29%。以1月29日收盘价计算，精研科技目前市盈率（TTM）约为142.84倍-190.46倍，市净率（LF）约3.73 倍，市销率（TTM）约3.01倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 近年来市盈率变化情况 (倍) 180 @ 20 120 90 60 2004 39-99 3998 30 298 25-08 0 -12-35 27.74 -30 2021-12-37 2020-12-37 2-06-30 2022-12-3- <1-06-30 2n- -○- 公司 -○- 行业均值 100 ହି ୨୦ 80 70 70g18 60 50 43d35 40 30 20 18 10 7.46 6.09 0 2020-12-37 1 2021-12-37 1 2022-72-37 1 2022-06-30 ' +-06-30 1-06-30 4- ...

证券日报网讯1月29日，联赢激光在互动平台回答投资者提问时表示，公司将保持高强度研发投入，通 过研发投入与技术创新，保持产品的技术优势，以优质可靠的产品为客户创造价值，同时提升公司盈利 水平和品牌价值。 ...

每经AI快讯，陕西华达1月29日晚间发布业绩预告，预计2025年归属于上市公司股东的净利润亏损5900 万元~7900万元，同比由盈转亏。业绩变动主要原因是，报告期公司各业务板块发展情况略有差异。其 中，防务领域部分产品价格下降，受客户项目节奏及产品验收周期等因素影响导致收入确认低于预期目 标；航天业务板块项目跟踪力度加强，发展稳健；民用通信领域保持稳定态势。此外，受产品生产所需 贵重金属等材料价格持续上涨，计提减值准备等因素影响，整体经营效益承压。公司紧盯前沿技术及行 业技术发展方向，加大研发投入，研发费用同比增长，研发实力持续提升，为后期发展筑牢根基。 （记者 张明双） 每经头条（nbdtoutiao）——水贝黄金平台"杰我睿"兑付危机调查：40倍杠杆对赌，金价越涨平台越 亏！老板自称"还在深圳"，投资者：兑付方案本金打两折，无法接受 ...

（记者 王晓波） 每经AI快讯，精研科技1月29日晚间发布业绩预告，预计2025年归属于上市公司股东的净利润4500万元 ~6000万元，同比下降49.87%~62.4%。业绩变动主要原因是，报告期内，公司持续加大研发及相关设备 投入，对损益的影响较上年同比增长了1.4亿元~1.6亿元。随着公司业务板块逐步多元化，公司积极配 合终端客户要求，在新项目、新材料及新技术方面积极开展研发，相应投入如材料投入、设备投入、人 员投入等明显提升，相关效益当期未能显现；2025年第四季度，受市场环境波动影响，公司业务结构及 营收结构较三季度发生变化，低毛利率产品占比提升；同时，四季度营收规模较三季度下滑，公司产能 未得到充分利用，固定成本无法摊薄，毛利率有所下降，受上述因素共同影响，拉低了公司报告期内盈 利水平。 每经头条（nbdtoutiao）——水贝黄金平台"杰我睿"兑付危机调查：40倍杠杆对赌，金价越涨平台越 亏！老板自称"还在深圳"，投资者：兑付方案本金打两折，无法接受 ...

品牌剖析 深度报告 美周新品 数据榜单 行业扫描 成分专研 趋势洞察 ● > #趋势洞察 @ 0 @ � 4 . ● � � . . 66 . . o e . . . . | 0 . . . . 0 . . . . e e 0 . ● "美妆产业 全链逐鹿IPO" 2025年美妆行业资本化的浪潮未歇，2026年开年便呈现密集发力态势：1月内，国货个护龙头半亩花田母公司山东花物堂、功效护肤代表HBN母公司深圳 护家科技相继向港交所递交招股书，此外，多家媒体披露，零售巨头屈臣氏已确定本轮IPO承销商，也意味着港伦双重上市再迈进了一步。 这些最新动态，为早已硝烟弥漫的美妆行业IPO战场，再添了一把旺火。 据用户说不完全统计，2025年至2026年1月已有近40家美妆企业密集发力，剑指A股、港股及美股市场。此次冲刺呈现出全产业链集体出战的态势：从上 游的原料包材商，到中游的品牌与运营商，再到下游的零售及数字服务商，无一缺席。 但繁荣背后，现实却很骨感。成功敲钟者寥寥，绝大多数企业仍身处上市辅导或递交招股书的漫长候场，在资本门槛前徘徊。即便如此，这些先行探路者 的动作，仍为行业提供了关键参照——它们究竟踩准了怎样的资本 ...